The Latest
-
Europe Could Conditionally Approve Gilead’s Remdesivir In Next Few Days
-
AstraZeneca Aiming For 30M UK Covid-19 Vaccine Doses By September
-
U.S. restriction on chipmakers deals critical blow to Huawei
-
The Fed issues a warning about the stock market: Morning Brief